Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model

We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated t...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2008
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23447
Acceso en línea:
https://doi.org/10.1016/j.vaccine.2008.08.014
https://repository.urosario.edu.co/handle/10336/23447
Palabra clave:
Apical membrane antigen 1
Carbon nanotube
Drug carrier
Polyclonal antibody
Amino terminal sequence
Animal experiment
Animal model
Article
Bagg albino mouse
Conjugation
Controlled study
Drug delivery system
Drug structure
Female
Immune system
Immunogenicity
Malaria
Mouse
Nonhuman
Parasitemia
Plasmodium berghei
Plasmodium vivax
Priority journal
Alleles
Amino acid sequence
Animals
Cytokines
Drug delivery systems
Enzyme-linked immunosorbent assay
Female
Fluorescent antibody technique
Hla-dr antigens
Malaria
Malaria vaccines
Membrane proteins
Mice
Molecular sequence data
Nanotubes
Plasmodium berghei
Plasmodium vivax
Protozoan proteins
Apical membrane antigen 1 (ama-1)
Functionalized carbon nanotubes (f-cnt)
Synthetic vaccine delivery system
protozoan
mhc class ii
subunit
western
inbred balb c
electron
Antigens
Blotting
Genes
Mice
Microscopy
Vaccines
Rights
License
Abierto (Texto Completo)
id EDOCUR2_c43845231b73e936fcb5e2281a497c7d
oai_identifier_str oai:repository.urosario.edu.co:10336/23447
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 0b3f2261-a522-4a91-ae3b-76200da750d0-10864ca35-5d05-418f-9e1e-6d745dabf423-10c194e2a-f1c6-4106-a89d-262d7d665683-1a66d3bf5-338f-463b-a488-32b0e6341cca-19e3ba9df-fe89-48fe-9521-cc8f452d56f5-1ed02648e-d655-4bbd-8d6e-90ad3efa4387-12020-05-26T00:02:05Z2020-05-26T00:02:05Z2008We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated to CNTs as well as being recognized by BALB/c polyclonal antibodies. Subsequent experiments lead us to assess the AMA-1 peptide alone, as well as the CNT-peptide conjugate regarding rodent malarial infection. Remarkably, the peptide effectively controlled and delayed Plasmodium berghei-challenged animals' parasitaemia. The peptide-CNT conjugate displayed similar immunological properties to the peptide alone by protecting or delaying malarial infection. The peptide presentation by f-CNT to the immune system thus constitutes a promising approach for synthetic malarial vaccine formulation since the immunogen peptide conformation is well preserved. © 2008 Elsevier Ltd. All rights reserved.application/pdfhttps://doi.org/10.1016/j.vaccine.2008.08.0140264410X13588745https://repository.urosario.edu.co/handle/10336/23447eng5873No. 465864VaccineVol. 26Vaccine, ISSN:0264410X, 13588745, Vol.26, No.46 (2008); pp. 5864-5873https://www.scopus.com/inward/record.uri?eid=2-s2.0-53449093079&doi=10.1016%2fj.vaccine.2008.08.014&partnerID=40&md5=f24cf4ad2c3fdb0f0fb8cc9ebd87a1a3Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURApical membrane antigen 1Carbon nanotubeDrug carrierPolyclonal antibodyAmino terminal sequenceAnimal experimentAnimal modelArticleBagg albino mouseConjugationControlled studyDrug delivery systemDrug structureFemaleImmune systemImmunogenicityMalariaMouseNonhumanParasitemiaPlasmodium bergheiPlasmodium vivaxPriority journalAllelesAmino acid sequenceAnimalsCytokinesDrug delivery systemsEnzyme-linked immunosorbent assayFemaleFluorescent antibody techniqueHla-dr antigensMalariaMalaria vaccinesMembrane proteinsMiceMolecular sequence dataNanotubesPlasmodium bergheiPlasmodium vivaxProtozoan proteinsApical membrane antigen 1 (ama-1)Functionalized carbon nanotubes (f-cnt)Synthetic vaccine delivery systemprotozoanmhc class iisubunitwesterninbred balb celectronAntigensBlottingGenesMiceMicroscopyVaccinesImmunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse modelarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Yandar, NubiaPastorin, GiorgiaPrato, MaurizioBianco, AlbertoPatarroyo, Manuel ElkinLozano, José Manuel10336/23447oai:repository.urosario.edu.co:10336/234472022-05-02 07:37:21.510716https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
spellingShingle Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
Apical membrane antigen 1
Carbon nanotube
Drug carrier
Polyclonal antibody
Amino terminal sequence
Animal experiment
Animal model
Article
Bagg albino mouse
Conjugation
Controlled study
Drug delivery system
Drug structure
Female
Immune system
Immunogenicity
Malaria
Mouse
Nonhuman
Parasitemia
Plasmodium berghei
Plasmodium vivax
Priority journal
Alleles
Amino acid sequence
Animals
Cytokines
Drug delivery systems
Enzyme-linked immunosorbent assay
Female
Fluorescent antibody technique
Hla-dr antigens
Malaria
Malaria vaccines
Membrane proteins
Mice
Molecular sequence data
Nanotubes
Plasmodium berghei
Plasmodium vivax
Protozoan proteins
Apical membrane antigen 1 (ama-1)
Functionalized carbon nanotubes (f-cnt)
Synthetic vaccine delivery system
protozoan
mhc class ii
subunit
western
inbred balb c
electron
Antigens
Blotting
Genes
Mice
Microscopy
Vaccines
title_short Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title_full Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title_fullStr Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title_full_unstemmed Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title_sort Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
dc.subject.keyword.spa.fl_str_mv Apical membrane antigen 1
Carbon nanotube
Drug carrier
Polyclonal antibody
Amino terminal sequence
Animal experiment
Animal model
Article
Bagg albino mouse
Conjugation
Controlled study
Drug delivery system
Drug structure
Female
Immune system
Immunogenicity
Malaria
Mouse
Nonhuman
Parasitemia
Plasmodium berghei
Plasmodium vivax
Priority journal
Alleles
Amino acid sequence
Animals
Cytokines
Drug delivery systems
Enzyme-linked immunosorbent assay
Female
Fluorescent antibody technique
Hla-dr antigens
Malaria
Malaria vaccines
Membrane proteins
Mice
Molecular sequence data
Nanotubes
Plasmodium berghei
Plasmodium vivax
Protozoan proteins
Apical membrane antigen 1 (ama-1)
Functionalized carbon nanotubes (f-cnt)
Synthetic vaccine delivery system
topic Apical membrane antigen 1
Carbon nanotube
Drug carrier
Polyclonal antibody
Amino terminal sequence
Animal experiment
Animal model
Article
Bagg albino mouse
Conjugation
Controlled study
Drug delivery system
Drug structure
Female
Immune system
Immunogenicity
Malaria
Mouse
Nonhuman
Parasitemia
Plasmodium berghei
Plasmodium vivax
Priority journal
Alleles
Amino acid sequence
Animals
Cytokines
Drug delivery systems
Enzyme-linked immunosorbent assay
Female
Fluorescent antibody technique
Hla-dr antigens
Malaria
Malaria vaccines
Membrane proteins
Mice
Molecular sequence data
Nanotubes
Plasmodium berghei
Plasmodium vivax
Protozoan proteins
Apical membrane antigen 1 (ama-1)
Functionalized carbon nanotubes (f-cnt)
Synthetic vaccine delivery system
protozoan
mhc class ii
subunit
western
inbred balb c
electron
Antigens
Blotting
Genes
Mice
Microscopy
Vaccines
dc.subject.keyword.eng.fl_str_mv protozoan
mhc class ii
subunit
western
inbred balb c
electron
Antigens
Blotting
Genes
Mice
Microscopy
Vaccines
description We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated to CNTs as well as being recognized by BALB/c polyclonal antibodies. Subsequent experiments lead us to assess the AMA-1 peptide alone, as well as the CNT-peptide conjugate regarding rodent malarial infection. Remarkably, the peptide effectively controlled and delayed Plasmodium berghei-challenged animals' parasitaemia. The peptide-CNT conjugate displayed similar immunological properties to the peptide alone by protecting or delaying malarial infection. The peptide presentation by f-CNT to the immune system thus constitutes a promising approach for synthetic malarial vaccine formulation since the immunogen peptide conformation is well preserved. © 2008 Elsevier Ltd. All rights reserved.
publishDate 2008
dc.date.created.spa.fl_str_mv 2008
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:02:05Z
dc.date.available.none.fl_str_mv 2020-05-26T00:02:05Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.vaccine.2008.08.014
dc.identifier.issn.none.fl_str_mv 0264410X
13588745
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23447
url https://doi.org/10.1016/j.vaccine.2008.08.014
https://repository.urosario.edu.co/handle/10336/23447
identifier_str_mv 0264410X
13588745
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 5873
dc.relation.citationIssue.none.fl_str_mv No. 46
dc.relation.citationStartPage.none.fl_str_mv 5864
dc.relation.citationTitle.none.fl_str_mv Vaccine
dc.relation.citationVolume.none.fl_str_mv Vol. 26
dc.relation.ispartof.spa.fl_str_mv Vaccine, ISSN:0264410X, 13588745, Vol.26, No.46 (2008); pp. 5864-5873
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-53449093079&doi=10.1016%2fj.vaccine.2008.08.014&partnerID=40&md5=f24cf4ad2c3fdb0f0fb8cc9ebd87a1a3
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167740299083776